Events

Seminar Series: Prognosis in Serious Neurological Disease: Opportunities and Challenges by Robert G. Holloway, M.D., M.P.H

Monday, Apr 11, 2022
12:00 pm - 1:00 pm
Add to iCal

Sheila Hutzler-Rives Memorial Lecture

Watch the Seminar

Formulating and communicating a prognosis in advanced neurological illness receives little attention but has profound consequences for patients and families. This presentation will review an approach to improve skills, reduce bias and to make you aware that even when patients and families hear you correctly, they form their own opinions. We will also explore the question: “Should physicians be superforecasters and what do we gain and lose by trying to achieve that ideal?

Robert G. Holloway Jr., MD, MPH, is Professor and Edward A. and Alma Vollertsen Rykenboer Chair of the Department of Neurology at the University of Rochester School of Medicine and Dentistry. He received his undergraduate (1985) and medical degrees from the University of Connecticut (1989), and his neurology (1993) and health services research training (MPH, 1996) at the University of Rochester. He has been on the faculty since 1993 and became Chair in 2013. Dr. Holloway is boarded in both Neurology and Palliative Medicine. His research interests are broad and include experimental therapeutics and outcomes research covering many areas of neurology. He is the PI on several institutional awards that support clinical trial research and career development. He has authored over 140 manuscripts, reviews, and editorials, and is co-editor of three books: Case Studies in Neuroscience, Primer on Palliative Care and Neuropalliative Care. He has been the recipient of numerous awards including the C. Miller Fisher Neuroscience Visionary Award, American Stroke Association, Dr. Robert Joynt Kindness Award, Junior Faculty Mentoring Award, Alpha Omega Alpha Faculty Inductee, Nominee, AAMC Humanism Award, and the Harry L. Segal Prize for Excellence in Third Year Teaching. His research interests are broad and include experimental therapeutics and outcomes research covering many areas of neurology. He is the PI on several institutional awards that support clinical trial research and career development.